(Q39816915)

14 September 2017

Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection (English)

1 reference

14 September 2017

experimental infection

1 reference

0 references

Peetermans WE

1

1 reference

14 September 2017

Hoogeterp JJ

2

1 reference

14 September 2017

Hazekamp-van Dokkum AM

3

1 reference

14 September 2017

van den Broek P

4

1 reference

14 September 2017

Mattie H

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

14 September 2017

6

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

14 September 2017

34

1 reference

14 September 2017

10

1 reference

14 September 2017

1869-1874

1 reference

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

In vitro activity and human pharmacokinetics of teicoplanin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Comparative in vitro study of teichomycin A2

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Microbiological properties of teicoplanin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171956

Cloxacillin and nafcillin: serum binding and its relationship to antibacterial effect in mice

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2149812

12 December 2020

inferred from PubMed ID database lookup

Kinetics of antimicrobial action

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2149812

12 December 2020

inferred from PubMed ID database lookup

Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2149812

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.34.10.1869

1 reference

14 September 2017

1 reference

14 September 2017

1 reference